Drugs / LSD
last change Sep 2012 re-read 3 minutes ago

LSD

Developed for
anxiety
Investigated by
Multidisciplinary Association for Psychedelic Studies

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00920387 Feb 2008 → Apr 2011 anxiety Multidisciplinary Association for Psychedelic Studies Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LSD ClinicalTrials.gov intervention name — accepted as the source's own label NCT00920387 ↗
Route Oral “Administering 200 mcg LSD orally once at the start of each of two day-long psychotherapy session” NCT00920387 ↗